Big Gain For CytomX Therapeutics, Inc.
Wed, May 01, 2024 at 07:21 PM
CytomX Therapeutics, Inc. (CTMX:NASDAQ) soared at $5.13, a gain of 214.7%. On Wed, May 01, 2024, CTMX:NASDAQ touched a New 2-Week High of $5.13. The stock appeared on our News Catalysts scanner on Wed, May 01, 2024 at 02:54 PM in the 'BIOTECH' category. From Wed, Apr 17, 2024, the stock recorded 40.00% Up Days and 18.18% Green Days
About CytomX Therapeutics, Inc. (CTMX:NASDAQ)
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is engaged in developing antibody therapeutics based on probody technology platform.
Top 10 Gainers:
- CytomX Therapeutics, Inc. (CTMX:NASDAQ), 214.72%
- SYLA Technologies Co. Ltd. (SYT:NASDAQ), 122.45%
- The Real Good Food Company Inc. (RGF:NASDAQ), 73.14%
- BioAtla Inc. (BCAB:NASDAQ), 49.45%
- Latch Inc. (LTCH:NASDAQ), 37.97%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 35.08%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 33.41%
- a.k.a. Brands Holding Corp. (AKA:NYSE), 31.63%
- Mediaco Holding Inc. (MDIA:NASDAQ), 30.68%
- Surmodics, Inc. (SRDX:NASDAQ), 29.74%